✦ LIBER ✦

Drug promotion: FDA steps in

✍ Scribed by Budiansky, Stephen

Book ID: 109727340
Publisher: Nature Publishing Group
Year: 1982
Tongue: English
Weight: 328 KB
Volume: 298
Category: Article
ISSN: 0028-0836
DOI: 10.1038/298784c0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FDA vs. free speech over drug promotions

✍ Anderson, Christopher 📂 Article 📅 1991 🏛 Nature Publishing Group 🌐 English ⚖ 275 KB

Drug Combinations: FDA in Earnest

📂 Article 📅 1969 🏛 Nature Publishing Group 🌐 English ⚖ 148 KB

Permitting Product Liability Litigation

Permitting Product Liability Litigation for FDA-Approved Drugs and Devices Promotes Patient Safety

✍ Kesselheim, A S 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

FDA aims for neutral tone in drug-reject

FDA aims for neutral tone in drug-rejection letters

📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 229 KB

Drug development in inflammatory bowel d

Drug development in inflammatory bowel disease: The role of the FDA

✍ Conor Lahiff; Sunanda Kane; Alan C. Moss 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 2 views

All medicinal compounds sold in the United States for inflammatory bowel disease (IBD) are regulated by the Food and Drug Administration (FDA) via a number of regulations dating back to 1906. The primary contemporary role of the FDA is in the assessment of safety and efficacy, and subsequent marketi

How the fda determines the “safety” of d

How the fda determines the “safety” of drugs: Are drugs used in obstetrics really “safe”?

✍ Doris Haire 📂 Article 📅 1982 🏛 Elsevier Science ⚖ 480 KB